Is CannBioRx Life Stock a Good Investment?
CannBioRx Life Investment Advice | ATNFW |
- Examine CannBioRx Life's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research CannBioRx Life's leadership team and their track record. Good management can help CannBioRx Life navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact CannBioRx Life's business and its evolving consumer preferences.
- Compare CannBioRx Life's performance and market position to its competitors. Analyze how CannBioRx Life is positioned in terms of product offerings, innovation, and market share.
- Check if CannBioRx Life pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about CannBioRx Life's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in CannBioRx Life Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if CannBioRx Life Sciences is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine CannBioRx Life Stock
Researching CannBioRx Life's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if CannBioRx Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CannBioRx Life's research are outlined below:
| CannBioRx Life is way too risky over 90 days horizon | |
| CannBioRx Life has some characteristics of a very speculative penny stock | |
| CannBioRx Life appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CannBioRx Life generates negative cash flow from operations | |
| CannBioRx Life has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Acquisition by Mcgovern Jr. Donald A. of 15000 shares of CannBioRx Life at 0.67 subject to Rule 16b-3 |
CannBioRx Life Quarterly Cost Of Revenue |
|
CannBioRx Life's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 250.78 M.Market Cap |
|
CannBioRx Life's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.93) | (5.18) | |
| Return On Capital Employed | (78.73) | (74.80) | |
| Return On Assets | (3.41) | (3.58) | |
| Return On Equity | 140.46 | 147.48 |
Determining CannBioRx Life's profitability involves analyzing its financial statements and using various financial metrics to determine if CannBioRx Life is a good buy. For example, gross profit margin measures CannBioRx Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CannBioRx Life's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in CannBioRx Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CannBioRx Life Sciences. Check CannBioRx Life's Beneish M Score to see the likelihood of CannBioRx Life's management manipulating its earnings.
Evaluate CannBioRx Life's management efficiency
CannBioRx Life Sciences has return on total asset (ROA) of (0.5162) % which means that it has lost $0.5162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.7419) %, meaning that it generated substantial loss on money invested by shareholders. CannBioRx Life's management efficiency ratios could be used to measure how well CannBioRx Life manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 147.48 in 2025, whereas Return On Tangible Assets are likely to drop (5.18) in 2025. CannBioRx Life reported Non Currrent Assets Other of (15.66 Million) in 2024. Intangibles To Total Assets is likely to climb to 0.70 in 2025, whereas Total Current Assets are likely to drop slightly above 4 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.39) | (0.37) | |
| Tangible Book Value Per Share | (5.30) | (5.04) | |
| Enterprise Value Over EBITDA | (0.03) | (0.03) | |
| Price Book Value Ratio | (13.85) | (13.16) | |
| Enterprise Value Multiple | (0.03) | (0.03) | |
| Price Fair Value | (13.85) | (13.16) | |
| Enterprise Value | 709.6 K | 674.1 K |
The strategic decisions made by CannBioRx Life management significantly impact its financial stability and market performance. Evaluating these factors helps determine whether the stock is a worthwhile investment.
Beta 0.215 |
Basic technical analysis of CannBioRx Stock
As of the 27th of March, CannBioRx Life shows the Risk Adjusted Performance of 0.0666, mean deviation of 8.01, and Downside Deviation of 10.31. CannBioRx Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CannBioRx Life Sciences downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if CannBioRx Life Sciences is priced correctly, providing market reflects its regular price of 0.0084 per share. As CannBioRx Life Sciences appears to be a penny stock we also recommend to validate its total risk alpha numbers.CannBioRx Life's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CannBioRx Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on CannBioRx Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CannBioRx Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Marrone Pamela G over a month ago Acquisition by Marrone Pamela G of 32037 shares of CannBioRx Life subject to Rule 16b-3 | ||
Feldmann Marc over six months ago Acquisition by Feldmann Marc of 135377 shares of CannBioRx Life subject to Rule 16b-3 | ||
Mcgovern Jr. Donald A. over a year ago Acquisition by Mcgovern Jr. Donald A. of 15000 shares of CannBioRx Life at 0.67 subject to Rule 16b-3 |
Understand CannBioRx Life's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing CannBioRx Life's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0666 | |||
| Market Risk Adjusted Performance | (0.63) | |||
| Mean Deviation | 8.01 | |||
| Semi Deviation | 8.67 | |||
| Downside Deviation | 10.31 | |||
| Coefficient Of Variation | 1478.72 | |||
| Standard Deviation | 15.24 | |||
| Variance | 232.21 | |||
| Information Ratio | 0.0671 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 1.06 | |||
| Sortino Ratio | 0.0992 | |||
| Treynor Ratio | (0.64) | |||
| Maximum Drawdown | 133.33 | |||
| Value At Risk | (12.62) | |||
| Potential Upside | 13.0 | |||
| Downside Variance | 106.24 | |||
| Semi Variance | 75.24 | |||
| Expected Short fall | (10.82) | |||
| Skewness | 4.16 | |||
| Kurtosis | 27.59 |
| Risk Adjusted Performance | 0.0666 | |||
| Market Risk Adjusted Performance | (0.63) | |||
| Mean Deviation | 8.01 | |||
| Semi Deviation | 8.67 | |||
| Downside Deviation | 10.31 | |||
| Coefficient Of Variation | 1478.72 | |||
| Standard Deviation | 15.24 | |||
| Variance | 232.21 | |||
| Information Ratio | 0.0671 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 1.06 | |||
| Sortino Ratio | 0.0992 | |||
| Treynor Ratio | (0.64) | |||
| Maximum Drawdown | 133.33 | |||
| Value At Risk | (12.62) | |||
| Potential Upside | 13.0 | |||
| Downside Variance | 106.24 | |||
| Semi Variance | 75.24 | |||
| Expected Short fall | (10.82) | |||
| Skewness | 4.16 | |||
| Kurtosis | 27.59 |
Consider CannBioRx Life's intraday indicators
CannBioRx Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CannBioRx Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 0.0084 | |||
| Day Typical Price | 0.0084 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | (0.0003) | |||
| Relative Strength Index | 43.11 |
CannBioRx Stock media impact
Far too much social signal, news, headlines, and media speculation about CannBioRx Life that are available to investors today. That information is available publicly through CannBioRx media outlets and privately through word of mouth or via CannBioRx internal channels. However, regardless of the origin, that massive amount of CannBioRx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of CannBioRx Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CannBioRx Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CannBioRx Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CannBioRx Life alpha.
CannBioRx Life Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards CannBioRx Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
CannBioRx Life Corporate Executives
Elected by the shareholders, the CannBioRx Life's board of directors comprises two types of representatives: CannBioRx Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CannBioRx. The board's role is to monitor CannBioRx Life's management team and ensure that shareholders' interests are well served. CannBioRx Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CannBioRx Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sir Feldman | CoFounder | Profile | |
| Pr Nanchahal | CoFounder Board | Profile | |
| Pr MD | CoFounder Board | Profile | |
| Ozan CFA | CFO Secretary | Profile |
Already Invested in CannBioRx Life Sciences?
The danger of trading CannBioRx Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CannBioRx Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CannBioRx Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CannBioRx Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for CannBioRx Stock Analysis
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.